Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-25-007819
Filing Date
2025-10-01
Accepted
2025-10-01 16:10:44
Documents
55
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q opgeninc_10q.htm   iXBRL 10-Q 750096
2 EXHIBIT 31.1 opgeninc_ex31-1.htm EX-31.1 18939
3 EXHIBIT 32.1 opgeninc_ex32-1.htm EX-32.1 8623
  Complete submission text file 0001829126-25-007819.txt   4346423

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE opgn-20250331.xsd EX-101.SCH 33548
5 XBRL CALCULATION FILE opgn-20250331_cal.xml EX-101.CAL 51806
6 XBRL DEFINITION FILE opgn-20250331_def.xml EX-101.DEF 152373
7 XBRL LABEL FILE opgn-20250331_lab.xml EX-101.LAB 265137
8 XBRL PRESENTATION FILE opgn-20250331_pre.xml EX-101.PRE 225709
57 EXTRACTED XBRL INSTANCE DOCUMENT opgeninc_10q_htm.xml XML 570400
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37367 | Film No.: 251364753
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)